Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)

Clinical trial NCT00156013 · COMPLETED

Trial details

NCT number: NCT00156013
Sponsor: Oncology Specialists, S.C.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-Cell Lymphoma, Non-Hodgkin

Start date: 2005-09-01
Primary completion: 2010-04-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.